Corcept Therapeutics Incorporated (CORT) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Corcept Therapeutics Incorporated (CORT) is Moderate Outperform.

The composite score behind that read is +0.39, weighing +0.43 of bullish evidence against -0.15 bearish.

Corcept Therapeutics Incorporated last closed at $121.19, +2.24% on the session.

Against the IVW growth benchmark the position is +1.44% over the forecast window.

The read is built from 15 underlying insights — 12 bullish and 3 bearish.

Agreement across those insights is 80%.

13 graded predictions for CORT so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Corcept Therapeutics Incorporated in the 2nd percentile on valuation and the 56th percentile on return on equity, where 100 is best.

Corcept Therapeutics Incorporated is classified under Health Care / Pharmaceuticals, with a market capitalisation of $12.81B.

StockMap tracks Corcept Therapeutics Incorporated as the 17th largest of the 151 companies it covers in the Pharmaceuticals industry, part of the Health Care sector.

Across that group the current two-week reads are 90 Neutral, 46 Moderate Underperform and 15 Moderate Outperform.

On that composite Corcept Therapeutics Incorporated ranks 1st of 151 in the group, against a group median of -0.08.